Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Akela Pharma Inc.
AKLPF
Healthcare
Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:AKLPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Jan 19, 2012 10:51am
RE: co-development revenue?
Any news recently?? Bio
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Nov 16, 2011 1:32pm
RE: co-development revenue?
To register such amount in financial statement , that suppose they decided mutually to end the development of Fentanyl Taifun.I believe that the share progresses because there is an
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(44)
•••
monstapeake
X
View Profile
View Bullboard History
Post by
monstapeake
on Nov 16, 2011 10:35am
co-development revenue?
The nr does not define co-development revenue. Seems like this may be a one-time infusion which makes the report look great. Anyone have an understanding of what is transpiring as the earnings look
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Post by
Biostocks01
on Sep 12, 2011 3:21pm
What happens??
Somebody knows??Bio
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Post by
Biostocks01
on Aug 09, 2011 10:10am
Akela Pharma Announces New Strategic
Akela Pharma Announces New Strategic Focus on Profitable PharmaForm Division07:00 EST Tuesday, Aug 09, 2011AUSTIN, TX, Aug. 9, 2011 /CNW/ - Akela Pharma, Inc. (TSX:AKL, 'Akela' or 'the
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Post by
Biostocks01
on Jun 16, 2011 8:20pm
Akela continuous to be profitable
AKELA PHARMA REPORTS RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 201100:39 EST Wednesday, Jun 15, 2011AUSTIN, TX, June 14, 2011 /CNW/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a drug
...more
(44)
•••
monstapeake
X
View Profile
View Bullboard History
Post by
monstapeake
on Jun 16, 2011 4:07pm
revenue growth and earnings released
first quarter is profitable. The bids were building during the day and I would anticipate some upward sp action tomorrow or possibly monday but who knows in this market. This little
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Post by
Biostocks01
on May 22, 2011 9:31am
First quarter results
WHen Akela will Announce First Quarter 2011 Financial Results??
(0)
•••
shambolic
X
View Profile
View Bullboard History
Post by
shambolic
on May 03, 2011 2:10pm
Any updates?
when is the next NR? Or anything that will increase the SP. Thx,.
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Apr 26, 2011 8:38pm
RE: RE: RE: What's up? EOM
A third quarter positive...very interesting!!These financial results will bring the confidence of the investors and maybe the new partner...BioConsultor...yes i receive your inbox...I am anxious to
...more
(0)
•••
Consultor1
X
View Profile
View Bullboard History
Comment by
Consultor1
on Apr 26, 2011 5:51pm
RE: RE: What's up? EOM
We should know more by the middle of May, as I stated in my last post we should easily pass .30. When the next quarter comes out and it is another positive, I will have to have another look. Charts
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Apr 25, 2011 8:22pm
RE: What's up? EOM
I believe that something major is preparing that why the price rise so high in a short time...Don't forget the number of shares of that stock held in public hand is very small
...more
(0)
•••
demdingbat
X
View Profile
View Bullboard History
Post by
demdingbat
on Apr 25, 2011 4:09pm
What's up? EOM
(0)
•••
Consultor1
X
View Profile
View Bullboard History
Comment by
Consultor1
on Apr 22, 2011 9:13am
RE: RE: RE: RE: Insider
Insiders continue to buy and last half hour of the day Anon was in and moved it up to .21. Believe we may see .30 plus range in the coming weeks. Next quarter should be out middle of May, and if it
...more
(0)
•••
Consultor1
X
View Profile
View Bullboard History
Comment by
Consultor1
on Apr 17, 2011 9:23am
RE: RE: RE: Insider
As soon as Gregory M. McKee, President & CEO of AKL start's putting out some up dates SP could easily move up to the .30-.50. Gregory can't keep saying it's the economy, or the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >